Table: begin end state 1 19 cytoplasmic 20 42 transmembrane 43 47 non-cytoplasmic 48 68 transmembrane 69 78 cytoplasmic 79 104 transmembrane 105 130 non-cytoplasmic 131 153 transmembrane 154 159 cytoplasmic 160 181 transmembrane 182 212 non-cytoplasmic 213 234 transmembrane 235 243 cytoplasmic 244 263 transmembrane 264 268 cytoplasmic 269 292 transmembrane 293 310 non-cytoplasmic 311 334 transmembrane 335 636 cytoplasmic
Input: >BWI76_RS27160 MSSDIKIKVQSFGRFLSNMVMPNIGAFIAWGIITALFIPTGWLPNETLAKLVGPMITYLL PLLIGYTGGKLVGGERGGVVGAITTMGVIVGADMPMFLGSMIAGPLGGWAIKKFDVWVDG KIKSGFEMLVNNFSAGIIGMILAILAFLGIGPAVEILSKILAAGVNFMVAHEMLPLASIF VEPAKILFLNNAINHGIFSPLGIQQSHELGKSIFFLIEANPGPGMGVLLAYMFFGRGSAK QSAGGAAIIHFLGGIHEIYFPYVLMNPRLILAVILGGMTGVFTLTILNGGLVSPASPGSI LAVLAMTPKGAYFANIAAIVAAMAVSFVVAAVLLKTSKVKEEDDIEAATRRMHDMKAESK GGATPLAAGDVANDLSHVRKIIVACDAGMGSSAMGAGVLRKKVQDAGLSNISVTNCAINN LPPDVDLVITHRDLTERAMRQVPQAQHISLTNFLDSGLYTSLTERLVAAQRHTDNEEKVR DSLKDSFDAADTNLFKLGAENIFLGRKAATKEEAILFAGEQLVKGGYVEPEYVQAMLDRE KLTSTYLGESIAVPHGTIEAKDRVLKTGIVFCQYPEGVRFGEEEDEVARLVIGIAARNNE HIQVITSLTNALDDESVIERLTKTTSVDEVLTLLKG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server